Subinhibitory concentrations of thymol reduce enterotoxins A and B and α-hemolysin production in Staphylococcus aureus isolates

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Qiu, Jiazhang ^a   Wang, Dacheng ^a   Xiang, Hua ^a   Feng, Haihua ^a   Jiang, Youshuai ^b   Xia, Lijie ^c   Dong, Jing ^a   Lu, Jing ^a   Yu, Lu ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b Heilongjiang August First Agricultural University   (China)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN A, STAPHYLOCOCCAL; ENTEROTOXIN B, STAPHYLOCOCCAL; HEMOLYSIN; HLB PROTEIN, STAPHYLOCOCCUS AUREUS; PRIMER DNA; SPHINGOMYELIN PHOSPHODIESTERASE; THYMOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL TOXINS; DNA PRIMERS; ENTEROTOXINS; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCUS AUREUS; THYMOL; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651453769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009736     Document Type: Article

References (39)

1. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
2. Koziel J, Maciag-Gudowska A, Mikolajczyk T, Bzowska M, Sturdevant DE, et al. (2009) Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One 4: e5210.
3. Ohlsen K, Koller K-P, Hacker J (1997) Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun 65: 3606-3614.
4. Yoh K, Kobayashi M, Yamaguchi N, Hirayama K, Ishizu T, et al. (2000) Cytokines and T-cell responses in superantigen-related glomerulonephritis following methicillin-resistant Staphylococcus aureus infection. Nephrol Dial Transplant 15: 1170-1174.
5. Omoe K, Ishikawa M, Shimoda Y, Hu DL, Ueda S, et al. (2002) Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates Harboring seg, seh, or sei genes. J Clin Microbiol 40: 857-62.
6. Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55: 165-199.
7. Aeschbach R, Scott BC, Murcia A, Butler J, Halliwell B, et al. (1994) Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol 32: 31-36.
8. Didry N, Dubreuil L, Pinkas M (1994) Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharm Acta Helv 69: 25-28.
9. Robledo S, Osorio E, Jaramillo LM, Restrepo A, Arango G, et al. (2005) In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives. Antimicrob Agents Chemother 49: 1652-1655.
10. Alam K, Nagi MN, Badary OA, Al-Shabanah OA, Al-Rikabi AC, et al. (1999) The protective action of thymol against carbon tetrachloride hepatotoxicity in mice. Pharmacol Res 40: 159-163.
11. Guo N, Wu X, Xiang H, Deng X, Yu L, et al. (2009) Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and-resistant Candida albicans. J Med Microbiol 58: 1074-1079.
12. Bi X, Guo N, Wang X, Deng X, Yu L, et al. (2009) The global gene expression profile of the model fungus Saccharomyces cerevisiae induced by thymol. J Appl Microbiol: in press.
13. Nostro A, Blanco AR, Cannatelli MA, Enea V, Flamini G, et al. (2004) Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiol Lett 230: 191-195.
14. McNamara PJ, Syverson RE, Milligan-Myhre K, Frolova O, Schroeder S, et al. (2009) Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1. Antimicrob Agents Chemother 53: 1898-1906.
15. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, et al. (1986) Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 202: 58-61.
16. Hall AE, Domanski PJ, Patel PR, Vernachio JH, Syribeys PJ, et al. (2003) Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 71: 6864-6870.
17. Smith-Palmer A, Stewart J, Fyfe L (2004) Influence of subinhibitory concentrations of plant essential oils on the production of enterotoxins A and B and alpha-toxin by Staphylococcus aureus. J Med Microbiol 53: 1023-1027.
18. Dorman HJ, Deans SG (2000) Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88: 308-316.
19. Escaich S (2008) Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 12: 400-408.
20. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6: 17-27.
21. Koszczol C, Bernardo K, Krönke M, Krut O (2006) Subinhibitory quinupristin/ dalfopristin attenuates virulence of Staphylococcus aureus. J Antimicrob Chemother 58: 564-574.
22. Herbert S, Barry P, Novick RP (2001) Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 69: 2996-3003.
23. Bernardo K, Pakulat N, Fleer S, Schnaith A, Utermöhlen O, Krut O, et al. (2004) Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48: 546-555.
24. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, et al. (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillinsensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195: 202-211.
25. Tranter HS, Tassou SC, Nychas GJ (1993) The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. J Appl Bacteriol 74: 253-259.
26. Shah S, Stapleton PD, Taylor PW (2008) The polyphenol (2)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett Appl Microbiol 46: 181-185.
27. Blickwede M, Wolz C, Valentin-Weigand P, Schwarz S (2005) Influence of clindamycin on the stability of coa and fnbB transcripts and adherence properties of Staphylococcus aureus Newman. FEMS Microbiol Lett 252: 73-78.
28. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, et al. (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106: 5883-5888.
29. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, et al. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101: 9786-9791.
30. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, et al. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426-2438.
31. Balaban N, Rasooly A (2000) Staphylococcal enterotoxins. Int J Food Microbiol 61: 1-10.
32. Goerke C, Fluckiger U, Steinhuber A, ZimmerliW, Wolz C (2001) Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alphatoxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol 40: 1439-1447.
33. Kuroda H, Kuroda M, Cui L, Hiramatsu K (2007) Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 268: 98-105.
34. Chan PF, Foster SJ (1998) Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 180: 6232-6241.
35. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI/ NCCLS document M100-S15. Clinical and Laboratory Standards Institute (CLSI). Wayne, PA.
36. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.
37. Rowe GE, Welch RA (1994) Assays of hemolytic toxins. Methods Enzymol 235: 657-667.
38. Sambanthamoorthy K, Smeltzer MS, Elasri MO (2006) Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus. Microbiology 152: 2559-2572.
39. Applied Biosystems, User bulletin no. 2 (1997) Relative quantification of gene expression.